Sun Biopharma Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
58.80
163.80
925.00
438.00
152.00
1,405
Total Accounts Receivable
373.70
226.90
733.00
321.00
420.00
332
Other Current Assets
0.30
0.40
74.00
118.00
195.00
110
Total Current Assets
432.80
391.10
1,732.00
877.00
767.00
1,847
Net Property, Plant & Equipment
19.20
13.00
-
-
-
-
Long-Term Note Receivable
80.20
-
-
-
-
-
Other Assets
-
3.00
-
-
-
51
Total Assets
532.30
407.10
1,732.00
877.00
767.00
1,898
ST Debt & Current Portion LT Debt
575.20
574.40
250.00
3,277.00
1,539.00
Accounts Payable
4.00
0.30
-
-
1,196.00
Other Current Liabilities
84.50
41.00
1,125.00
2,242.00
1,435.00
Total Current Liabilities
663.70
615.70
1,375.00
5,519.00
4,170.00
Long-Term Debt
6.50
2.40
2,999.00
-
286.00
Other Liabilities
-
-
39.00
-
-
Total Liabilities
670.20
618.10
4,413.00
5,519.00
4,456.00
Common Equity (Total)
338.00
411.10
2,681.00
4,642.00
3,689.00
Total Shareholders' Equity
137.90
211.00
2,681.00
4,642.00
3,689.00
Total Equity
137.90
211.00
2,681.00
4,642.00
3,689.00
Liabilities & Shareholders' Equity
532.30
407.10
1,732.00
877.00
767.00
Preferred Stock (Carrying Value)
200.10
200.10
-
-
-

About Sun Biopharma

View Profile
Address
712 Vista Boulevard
Waconia Minnesota 55387
United States
Employees -
Website http://www.sunbiopharma.com
Updated 07/08/2019
Sun BioPharma Inc. is a clinical-stage biopharmaceutical company, which engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis. The company was founded by Michael Cullen and Thomas Neenan in 2011 and is headquartered in Waconia, MN.